Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
19,358
Total Claims
$1.2M
Drug Cost
464
Beneficiaries
$2,686
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+129%
Cost per patient vs peers
$2,686 vs $1,174 avg
+29%
Brand preference vs peers
11.5% vs 8.9% avg
Brand vs Generic
Brand: 2,176 claims · $792K
Generic: 16,805 claims · $445K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 236 | $137K |
| Linaclotide | 156 | $89K |
| Chlorpromazine Hcl | 136 | $69K |
| Aripiprazole | 16 | $46K |
| Sitagliptin Phosphate | 67 | $39K |
| Budesonide/Formoterol Fumarate | 85 | $35K |
| Dulaglutide | 33 | $33K |
| Sacubitril/Valsartan | 45 | $32K |
| Rivaroxaban | 52 | $30K |
| Icosapent Ethyl | 80 | $28K |
| Linagliptin | 38 | $21K |
| Quetiapine Fumarate | 1,012 | $21K |
| Insulin Detemir | 65 | $21K |
| Collagenase Clostridium Hist. | 49 | $20K |
| Aripiprazole | 63 | $20K |
Prescribing Profile
Patient Profile
79
Avg Age
68%
Female
2.84
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data